Research study Program year 2020 Source: CMS Open Payments

An Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerabil

Research payments

$227,335

25 payments

Through program year 2020, $227,335 in research payments was reported against An Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerabil, across 25 payments, paid by GlaxoSmithKline, LLC..

Paid by
GlaxoSmithKline, LLC.
ClinicalTrials.gov
No trial number was reported for this study

By program year

2 rows
Year Kind Amount Payments
2020 Research $27,586 6
2019 Research $199,749 19

Breakdown

Who paid Research payments · program years 2019–2020
  1. GlaxoSmithKline, LLC. $227,335 25 payments
Who received the money Research payments · program years 2019–2020
  1. Ut Southwestern Medical Center Organisation paid for research $118,280 2 payments
  2. University of Pittsburgh Physicians Organisation paid for research $63,314 5 payments
  3. The University Of Texas Southwestern Medical Center At Dallas Organisation paid for research $18,542 2 payments
  4. University Of Pittsburgh Organisation paid for research $13,018 5 payments
  5. The University Of Texas Southwestern Medical Center Organisation paid for research $3,650 2 payments
  6. Univ Of Tx Sw Med Center Organisation paid for research $2,658 2 payments
  7. University Of Pittsburgh Medical Centre Organisation paid for research $2,596 1 payment
  8. Lundquist Institute For Biomedical Innovation Organisation paid for research $2,577 3 payments
  9. La Biomedical Research Organisation paid for research $1,900 2 payments
  10. The University Of Texas Organisation paid for research $800 1 payment

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record